Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Toscano

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Oncogene|March 18, 2008
P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cellsF Toscano, Z El Fajoui, F Gay, et al.
Scientific Reports|July 22, 2021
Author Correction: Differential expression of circulating exosomal microRNAs in refractory intracranial atherosclerosis associated with antiangiogenesisHao Jiang, Juan F Toscano, Shlee S Song, et al.
Scientific Reports|December 21, 2019
Differential expression of circulating exosomal microRNAs in refractory intracranial atherosclerosis associated with antiangiogenesisHao Jiang, Juan F Toscano, Shlee S Song, et al.
Cell Death and Differentiation|March 17, 2012
dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8Y Estornes, F Toscano, F Virard, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|November 6, 2018
Differential Expression of Vascular Endothelial Growth Factor-A<sub>165</sub> Isoforms Between Intracranial Atherosclerosis and Moyamoya DiseaseHao Jiang, Juan F Toscano, Michael Schiraldi, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|October 29, 2020
Encephaloduroarteriosynangiosis (EDAS) revascularization for symptomatic intracranial atherosclerotic steno-occlusive (ERSIAS) Phase-II objective performance criterion trialNestor R Gonzalez, Hao Jiang, Patrick Lyden, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Patient-Reported Experience Measures (PREMs) in patients with metastatic colorectal cancer undergoing treatment supported by feedback auditing: the EPIC studyA Sartore-Bianchi, F Toscano, D P Bernasconi, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 26, 2020
Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practiceE Pérez-Ruiz, J Jiménez-Castro, M-A Berciano-Guerrero, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Oncogene|March 18, 2008
P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cellsF Toscano, Z El Fajoui, F Gay, et al.
Scientific Reports|July 22, 2021
Author Correction: Differential expression of circulating exosomal microRNAs in refractory intracranial atherosclerosis associated with antiangiogenesisHao Jiang, Juan F Toscano, Shlee S Song, et al.
Scientific Reports|December 21, 2019
Differential expression of circulating exosomal microRNAs in refractory intracranial atherosclerosis associated with antiangiogenesisHao Jiang, Juan F Toscano, Shlee S Song, et al.
Cell Death and Differentiation|March 17, 2012
dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8Y Estornes, F Toscano, F Virard, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|November 6, 2018
Differential Expression of Vascular Endothelial Growth Factor-A<sub>165</sub> Isoforms Between Intracranial Atherosclerosis and Moyamoya DiseaseHao Jiang, Juan F Toscano, Michael Schiraldi, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|October 29, 2020
Encephaloduroarteriosynangiosis (EDAS) revascularization for symptomatic intracranial atherosclerotic steno-occlusive (ERSIAS) Phase-II objective performance criterion trialNestor R Gonzalez, Hao Jiang, Patrick Lyden, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Patient-Reported Experience Measures (PREMs) in patients with metastatic colorectal cancer undergoing treatment supported by feedback auditing: the EPIC studyA Sartore-Bianchi, F Toscano, D P Bernasconi, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 26, 2020
Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practiceE Pérez-Ruiz, J Jiménez-Castro, M-A Berciano-Guerrero, et al.
Pageof 4